We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $468M
1-Year Est. Return 6.67%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+6.67%
3 Year Est. Return
+57.25%
5 Year Est. Return
+83.16%
10 Year Est. Return
+253.32%
AUM
$464M
AUM Growth
+$42.7M
Cap. Flow
+$17.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
44.98%
Holding
73
New
2
Increased
31
Reduced
23
Closed
4

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$17.3M
2
SABR icon
Sabre
SABR
+$5.72M
3
WBA
Walgreens Boots Alliance
WBA
+$5.1M
4
MSI icon
Motorola Solutions
MSI
+$3.44M
5
TTE icon
TotalEnergies
TTE
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 30.37%
2 Technology 17.1%
3 Industrials 15.91%
4 Financials 11.31%
5 Consumer Staples 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
1
Medtronic
MDT
$117B
$46.7M 10.08%
579,946
+221,748
+62% +$17.3M
JNJ icon
2
Johnson & Johnson
JNJ
$646B
$24.2M 5.21%
194,087
+10,093
+5% +$1.21M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$22.3M 4.8%
268,117
+60,834
+29% +$5.1M
MSFT icon
4
Microsoft
MSFT
$3.81T
$20.2M 4.35%
306,618
+12,983
+4% +$832K
ORCL icon
5
Oracle
ORCL
$435B
$18.7M 4.04%
419,759
+23,689
+6% +$986K
WFC icon
6
Wells Fargo
WFC
$262B
$18.3M 3.95%
328,739
-2,279
-0.7% -$129K
AON icon
7
Aon
AON
$75.4B
$17M 3.67%
143,558
+11,792
+9% +$1.36M
JCI icon
8
Johnson Controls International
JCI
$84.6B
$14.2M 3.05%
336,208
+24,413
+8% +$1.03M
AXP icon
9
American Express
AXP
$225B
$13.8M 2.98%
174,922
+10,931
+7% +$855K
MSI icon
10
Motorola Solutions
MSI
$80.4B
$13.2M 2.84%
152,537
+42,099
+38% +$3.44M
RTX icon
11
RTX Corp
RTX
$285B
$13M 2.81%
184,553
+21,167
+13% +$1.49M
PEP icon
12
PepsiCo
PEP
$193B
$13M 2.8%
116,218
+21,661
+23% +$2.32M
PFE icon
13
Pfizer
PFE
$159B
$12.9M 2.78%
397,688
+5,466
+1% +$172K
UNP icon
14
Union Pacific
UNP
$183B
$11.9M 2.57%
112,724
+4,381
+4% +$467K
VZ icon
15
Verizon
VZ
$208B
$11.7M 2.52%
239,474
-39,665
-14% -$1.99M
BAX icon
16
Baxter International
BAX
$13.5B
$11.3M 2.43%
217,302
-56,145
-21% -$2.76M
CSCO icon
17
Cisco
CSCO
$433B
$9.93M 2.14%
293,809
+25,199
+9% +$817K
COL
18
DELISTED
Rockwell Collins
COL
$9.67M 2.09%
99,519
+25,796
+35% +$2.43M
TFCFA
19
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$9.65M 2.08%
297,871
-629
-0.2% -$19.2K
GWW icon
20
W.W. Grainger
GWW
$61.5B
$8.34M 1.8%
35,830
-1,056
-3% -$260K
CHKP icon
21
Check Point Software Technologies
CHKP
$14.1B
$7.9M 1.7%
76,994
-23,340
-23% -$2.29M
APA icon
22
APA Corp
APA
$14.9B
$7.15M 1.54%
139,199
-5,011
-3% -$282K
BTI icon
23
British American Tobacco
BTI
$121B
$7M 1.51%
105,527
+21,707
+26% +$1.34M
TIF
24
DELISTED
Tiffany & Co.
TIF
$7M 1.51%
73,437
-17,129
-19% -$1.46M
BHI
25
DELISTED
Baker Hughes
BHI
$6.96M 1.5%
116,401
+16,607
+17% +$1.01M

Similar funds

Foyston, Gordon, & Payne's Q1 2017 Portfolio in Review

As of Q1 2017, Foyston, Gordon, & Payne held 73 positions worth $464M, up 10% from $421M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Foyston, Gordon, & Payne deployed $17.5M of net new capital in Q1 2017, opening 2 new positions and adding to 31 existing holdings. Its largest new stake was Sabre: 249,809 shares worth $5.29M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Compañía de Cervecerías Unidas, an estimated $4.44M trimmed.

  • Foyston, Gordon, & Payne's largest Q1 2017 buy was Sabre: 249,809 shares worth $5.29M.
  • Foyston, Gordon, & Payne added most to Medtronic in Q1 2017, an estimated $17.3M increase.
  • Foyston, Gordon, & Payne's biggest Q1 2017 reduction was Compañía de Cervecerías Unidas, cutting an estimated $4.44M.
  • Foyston, Gordon, & Payne fully exited M&T Bank in Q1 2017, selling an estimated $3.7M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 45% of its $464M portfolio in Q1 2017.
  • Foyston, Gordon, & Payne opened 2 new positions and closed 4 in Q1 2017.
  • Foyston, Gordon, & Payne's portfolio value rose 10% quarter-over-quarter to $464M.

Based on Foyston, Gordon, & Payne's 13F filing for Q1 2017, filed 12 May 2017.